Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9VXY

Cryo-EM Structure of Nipah Virus Polymerase in complex with GL22

This is a non-PDB format compatible entry.
Summary for 9VXY
Entry DOI10.2210/pdb9vxy/pdb
EMDB information65445
DescriptorRNA-directed RNA polymerase L, Phosphoprotein, ZINC ION, ... (4 entities in total)
Functional Keywordspolymerase, inhibitor, nipah virus, complex, replication
Biological sourceHenipavirus nipahense
More
Total number of polymer chains5
Total formula weight571944.98
Authors
Xue, L.,Gui, J.,Chang, T.,Pan, H.,Xiong, X. (deposition date: 2025-07-20, release date: 2026-04-29, Last modification date: 2026-05-13)
Primary citationXue, L.,Gui, J.,Gao, S.,Gao, X.,Chang, T.,Pan, H.,Tang, J.,Zhang, M.,Li, Z.,Zou, B.,Zhao, H.,Wang, L.,Li, M.,Rong, L.,Plemper, R.K.,Chen, X.,He, J.,Pei, R.,Zhan, P.,Xiong, X.
Differential inhibition of Morbillivirus and Henipavirus polymerases by ERDRP-0519 and structure-guided inhibitor optimization.
Cell, 2026
Cited by
PubMed Abstract: ERDRP-0519 is a non-nucleoside polymerase inhibitor developed against measles virus (MeV) of the Morbillivirus genus. Here, we show that ERDRP-0519 also cross-inhibits Nipah virus (NiV) of the Henipavirus genus with reduced potency. ERDRP-0519 binds to a shared pocket within the RNA-dependent RNA polymerase (RdRp) palm domains of MeV, peste des petits ruminants virus (PPRV), and NiV polymerases. ERDRP-0519 forms more extensive interactions with Morbillivirus polymerases, whereas binding to NiV polymerase requires substantial RdRp motif rearrangements, likely incurring an energetic cost and resulting in reduced affinity. ERDRP-0519 binding impedes RNA synthesis by sterically blocking RNA and nucleotide binding. Guided by these insights, we designed GL22 and G671, ERDRP-0519 derivatives with extended moieties that engage additional cross-domain RdRp contacts in the NiV polymerase. These derivatives exert more extensive steric hindrance to RNA and nucleotide binding, enhancing biochemical inhibition potency. These findings elucidate the molecular mechanism of ERDRP-0519 action and guide structure-based inhibitor design.
PubMed: 42061399
DOI: 10.1016/j.cell.2026.04.011
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.87 Å)
Structure validation

254917

PDB entries from 2026-06-10

PDB statisticsPDBj update infoContact PDBjnumon